CG
DGX icon

Caprock Group’s Quest Diagnostics DGX Stock Holding History

Caprock Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Sell
5,557
-157
-3% -$30.8K 0.02% 578
2026
Q1 		$1.12M Buy
5,714
+799
+16% +$155K 0.03% 512
2025
Q4 		$853K Buy
+4,915
New +$895K 0.02% 642
2025
Q1 		$250K Sell
1,479
-1,749
-54% -$287K 0.01% 934
2024
Q4 		$487K Buy
3,228
+252
+8% +$39.2K 0.02% 630
2024
Q3 		$462K Sell
2,976
-283
-9% -$42.3K 0.02% 595
2024
Q2 		$446K Buy
3,259
+593
+22% +$81.2K 0.02% 561
2024
Q1 		$355K Sell
2,666
-38
-1% -$4.93K 0.02% 512
2023
Q4 		$373K Sell
2,704
-8
-0.3% -$1.05K 0.02% 474
2023
Q3 		$330K Sell
2,712
-77
-3% -$10.3K 0.03% 470
2023
Q2 		$392K Sell
2,789
-331
-11% -$45.6K 0.03% 433
2023
Q1 		$441K Buy
3,120
+8
+0.3% +$1.15K 0.03% 390
2022
Q4 		$487K Sell
3,112
-1,969
-39% -$283K 0.05% 288
2022
Q3 		$623K Sell
5,081
-56
-1% -$7.38K 0.06% 234
2022
Q2 		$683K Buy
5,137
+1,964
+62% +$268K 0.07% 216
2022
Q1 		$434K Buy
3,173
+36
+1% +$5.02K 0.04% 327
2021
Q4 		$543K Buy
3,137
+6
+0.2% +$913 0.04% 265
2021
Q3 		$455K Buy
3,131
+110
+4% +$16.1K 0.04% 276
2021
Q2 		$399K Sell
3,021
-195
-6% -$25.5K 0.04% 298
2021
Q1 		$413K Buy
+3,216
New +$396K 0.05% 267

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Caprock Group's DGX Position: Q2 2026 in Review

Caprock Group reduced its Quest Diagnostics (DGX) stake by 2.7% in Q2 2026, selling an estimated $30.8K and leaving 5,557 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #578.

Caprock Group first reported a position in DGX in Q1 2021 and has held it in 20 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Caprock Group held 5,557 shares of Quest Diagnostics worth $1.18M as of Q2 2026.
  • Caprock Group sold 157 Quest Diagnostics shares in Q2 2026, an estimated $30.8K.
  • Quest Diagnostics made up 0.02% of Caprock Group's portfolio in Q2 2026, its #578 holding.
  • Caprock Group first reported a position in Quest Diagnostics in Q1 2021 and has held it in 20 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.